Darrin Disley
Vermögen: 290 589 $ am 31.12.2025
Vermögen: 290 589 $ am 31.12.2025
Dr. Darrin M.
Disley is an Executive Chairman at Cardiogeni Plc and a Non-Executive Chairman at Cell Therapy Ltd. Dr. Disley was previously employed as a Managing Director & Director by Coiled Therapeutics Plc, a Chairman by Desktop Genetics Ltd., a President, CEO & Executive Director by Horizon Discovery Group Ltd., a Chief Executive Officer & Director by Mogrify Ltd., and a President, Chief Executive Officer & Director by Revvity Discovery Ltd. He also served on the board at GeoSpock Ltd., Oncogeni Ltd. and The Bioindustry Association.
He received his doctorate degree from the University of Cambridge.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 3.16% | 31.03.2025 | 2’816’017 ( 3.16% ) | 264 030 $ | 31.12.2025 |
| 03.12.2024 | 202’420 ( 0.05% ) | 26 560 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Vorsitzender | - |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Vorsitzender | 12.04.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Mogrify Ltd.
Mogrify Ltd. BiotechnologyHealth Technology Develops cellular conversion technology solutions | Vorstandsvorsitzender | 30.04.2025 |
| HORIZON DISCOVERY GROUP PLC | Vorstandsvorsitzender | 20.02.2018 |
GeoSpock Ltd.
GeoSpock Ltd. Data Processing ServicesTechnology Services Provides data software products | Gründer | 16.11.2017 |
| ROQT THER | Vorstandsvorsitzender | - |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Commercial Services |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
GeoSpock Ltd.
GeoSpock Ltd. Data Processing ServicesTechnology Services Provides data software products | Technology Services |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Technology Services |
Horizon Discovery Group Ltd.
Horizon Discovery Group Ltd. Medical DistributorsDistribution Services Sells cell engineering tools and services for biopharmaceutical and diagnostics companies, contract research & manufacturing organizations and academic researchers | Distribution Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Mogrify Ltd.
Mogrify Ltd. BiotechnologyHealth Technology Develops cellular conversion technology solutions | Health Technology |
Roquefort Therapeutics Plc
Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen